Samtidig behandling med losartan og rifampicin (inducer af metabolismeenzymer) gav en reduktion på 40% i plasmakoncentrationen af den aktive metabolit.
It was found that concomitant treatment of losartan with rifampicine (inducer of matabolism enzymes) gave a 40% reduction in plasma concentration of the active metabolite.